Abstract-Enhanced activation of the endothelial mineralocorticoid receptor contributes to the development of arterial stiffness, which is an independent predictor of cardiovascular disease. Previously, we showed that enhanced endothelium mineralocorticoid receptor signaling in female mice prompts expression and translocation of the α-subunit of the epithelial sodium channel to the endothelial cell (EC) surface (EnNaC) inducing vascular fibrosis and stiffness. Further, amiloride, an epithelial sodium channel antagonist, inhibits vascular fibrosis, remodeling, and stiffness induced by feeding a Western diet high in saturated fat and refined carbohydrates. However, how this occurs remains unknown. Thereby, we hypothesized that endothelial cell-specific EnNaC activation is necessary for aldosterone-mediated endothelium stiffness. To address this notion, EnNaC α-subunit knockout (EnNaC −/− ) and wild-type littermate female mice were administrated aldosterone (250 µg/kg per day) via osmotic minipumps for 3 weeks beginning at 25 to 28 weeks of age. In isolated mouse endothelial cells, inward sodium currents were significantly reduced in amiloride controls, as well as in EnNaC −/− . Likewise, aldosterone-induced endothelium stiffness was increased and endothelium-dependent relaxation less in EnNaC −/− versus wild-type. Further, EnNaC −/− mice exhibited attenuated responses to aldosterone infusion, including aortic endoplasmic reticulum stress, endothelium nitric oxide synthase activation, endothelium permeability, expression of proinflammatory cytokines, oxidative stress, and aortic collagen 1 deposition, supporting the notion that αEnNaC subunit activation contributes to these vascular responses. (Hypertension. 2018;72:731-738.
I
ncreased arterial stiffness, characterized by increased pulse wave velocity (PWV), is associated with an increased risk for cardiovascular disease (CVD). 1 In this context, a metaanalysis of 17 longitudinal studies in 15 877 people showed that an increase of 1 m/s in PWV increased CVD events by 14%, CVD mortality by 15%, and all-cause mortality by 15%. 2 Further, in the data from the Framingham Heart Study, which included 2232 people, the presence of arterial stiffness was an independent predictor of CVD and associated morbidity and mortality. 3 Recent data support the notion that aldosterone, acting through the endothelial cell (EC) mineralocorticoid receptor (MR), promotes arterial stiffness and impairs endothelial-mediated relaxation. 4, 5 In this regard, aldosterone, but not glucocorticoids, stimulates the ECMR, as the EC possesses the enzyme 11β-hydroxysteroid dehydrogenase 2 which inactivates glucocorticoids. 6, 7 On activation by aldosterone, the ECMR translocates to the nucleus to modulate gene transcription and translation of proteins by binding to hormone/ steroid response elements or negative response elements DNA sequences. 8, 9 Aldosterone also exerts rapid nongenomic effects to affect increased cytosolic calcium levels, oxidative stress, endoplasmic reticulum (ER) stress, and cell death by activation of extracellular receptor kinase, Rho kinase, and protein kinase C. [10] [11] [12] Classically, the epithelial sodium (Na + ) channel (ENaC), located in the apical membrane of renal aldosterone-responsive epithelia, plays an essential role in controlling Na + balance and blood pressure. 13 ENaC consists of 3 subunits, α, β, and γ. Although the α/β-subunit is essential for proper channel function, the γ-subunits act as amplifiers. 13, 14 Recent data have also shown that ENaC exists in the endothelium (EnNaC) and regulates cardiovascular stiffness and function. [15] [16] [17] Our recent work suggests that aldosterone enhances ECMR signaling, in part, by inducing translocation of EnNaC to the plasma membrane of the aortic ECs.
9 Nedd4-2 (E3 ubiquitin ligase) and SGK1
(serum/glucocorticoid regulated kinase 1) were also shown to be involved in the aldosterone-induced ENaC expression and activation. 13, 18 In this regard, enhanced SGK1 inhibits ubiquinization by upregulation of Nedd4-2, which acts as a negative role in controlling EnNaC cell surface expression, leading to increased membrane localization of this sodium channel and associated vascular stiffness. 13, 18 Meanwhile, EnNaC activation is associated with an increase in inward Na + currents and endothelial stiffening. 9, 13 Here, we explore the notion that activated ECMR promotes endothelial stiffness through increased EnNaC synthesis/activation, enhanced EC membrane localization, and endothelial stiffness. 9, 13 Females with obesity and diabetes mellitus lose the CVD protection that is typically afforded by female sex and that this may be related to an increased propensity to develop cardiovascular stiffness. Our previous data found that C57BL6J mice fed a Western diet, high in refined carbohydrates and saturated fat, became overweight and insulin resistant and there was a more rapid onset of aortic 19 and cardiac stiffness 20 in females compared with males. In addition, we found higher plasma aldosterone levels in females compared with males. 20 Inhibition of EnNaC with low doses of nonpressor and nonsodium retaining doses of the ENaC antagonist, amiloride improved endothelialmediated relaxation and decreased arterial oxidative stress, fibrosis, and stiffness without affecting blood pressure or Na + retention, 19 suggesting a specific role for EnNaC in promoting fibrosis and stiffness. Recent work also supports the concept that aldosterone stimulation of ECMRs increases EnNaC membrane abundance in ECs, induces Na + entry, and triggers the polymerization of G-actin to F-actin, resulting in reduction of eNOS (endothelium nitric oxide [NO] synthase) activity and NO production and thus excessive arterial stiffness. [21] [22] [23] Thus, we hypothesized that EC-specific αEnNaC activation is necessary for aldosteronemediated endothelium stiffness through increases in endothelial ER stress, which leads to reduced eNOS activity, increased endothelium permeability, expression of proinflammatory cytokines, and oxidative stress.
Methods
The data that support the findings in this study are available from the corresponding authors on reasonable request. The αEnNaC subunit knockout (EnNaC −/− ) mice were generated and crossed with Tie 2 Cre + mice and wild-type littermates as described before. 17 A detailed description of experimental procedures, including EC isolation, patch clamp technique, aortic stiffness measurement, endothelium permeability, gene expressions in Western blot, real-time polymerase chain reaction, as well as immunohistochemistry, is available in the online-only Data Supplement. Results are reported as means±SEM. Differences in outcomes were determined using 1-way ANOVA multiple comparison analysis and Gabriel Student-Newman-Keuls posttest or paired t tests and were considered significant when P<0.05. All statistical analyses were performed using Sigma Plot (version 12) software (Systat Software).
Results

Effects of Aldosterone Infusion on Characteristics of Mice
EnNaC −/− does not impact systolic blood pressure and heart rate under normal physiological conditions, as previously reported. 17 There were no significant differences in body weight and fat mass between EnNaC −/− and their littermate controls (Table S1 online-only Data Supplement). Chronic aldosterone infusion did not alter these parameters (Table S1 ). Of note, there were also no significant differences in serum albumin, serum Na + , fasting glucose, homeostatic model assessment-insulin resistance, plasma urea nitrogen, creatinine, urine protein, as well as potassium (K + ) in all 4 experimental groups (Table S1 ). However, aldosterone decreased urine Na + that was not prevented in aldosterone EnNaC −/− mice (Table S1 ).
EnNaC Antagonist and EnNaC −/− Represses Inward Na + Currents in Cultured ECs
Previous research has shown that plasma aldosterone levels reach >2000 pMol in mice infused aldosterone (288 µg/kg per day) for 4 weeks. 24 On the basis of this, it was assumed that there were higher levels of aldosterone in current study. Aldosterone-increased MR mRNA expression in aortic tissues that were not prevented by the EnNaC −/− genotype ( Figure  S2 ). To evaluate the effect of aldosterone and EnNaC on Na + currents in isolated ECs from these mice, Na + currents were evaluated via patch clamp in the absence or presence of amiloride (1 µmol). Amiloride inhibited inward Na + currents in the wild-type (WT) cultured ECs ( Figure 1A and 1B). After 3 weeks of aldosterone infusion, the isolated ECs from EnNaC −/− mice exhibited less inward Na + currents in comparison to those from EnNaC WT mice ( Figure 1C-1E ), suggesting that EnNaC mediates aldosterone-induced increase in Na + currents.
αEnNaC Mediates Aldosterone-Induced Aortic Endothelium Stiffness and Impairment of Vasodilation
Three weeks of aldosterone infusion induced an increase in ex vivo endothelium stiffness but not in vivo PWV in EnNaC WT mice. The increased ex vivo endothelium stiffness in EnNaC WT mice was blunted in EnNaC −/− mice ( Figure 2A and 2B). Meanwhile, chronic aldosterone infusion impaired endothelium vasodilatory responses to acetylcholine ( Figure 2C ) but not to sodium nitroprusside ( Figure 2D ). Further, αEnNaC inactivation prevented aldosterone-induced impairment of aortic relaxation, suggesting that EnNaC activation promotes endothelial stiffness and decreases endothelial-mediated relaxation on chronic aldosterone stimulation.
αEnNaC Mediates Aldosterone-Induced Aortic ER Stress and Attenuation of eNOS Activation
In response to aldosterone stimulation, GRP78 (glucoseregulated protein), a major chaperone in ER, controlling the folding and assembly of proteins, was increased in EnNaC WT mice ( Figure 3 ). This change was associated with reduced eNOS activity. Likewise, EnNaC −/− prevented chronic aldosterone infusion-induced increases in GRP78 expression and reduction of eNOS activity. The chronic aldosterone infusion-induced increases in GRP78 expression and reduction of eNOS activity were not observed in EnNaC −/− ( Figure 3 ). Thus, αEnNaC mediated aldosterone-induced ER stress is associated with reduced eNOS activity.
αEnNaC Mediates Aldosterone-Induced Expression of Endothelium Adhesion Molecules, Permeability, and Proinflammatory Cytokines
Endothelial stiffness promotes EC cell expression of adhesion molecules, including ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule-1), which, in turn, induces leukocyte/macrophage migration, adhesion, and infiltration. 25 Chronic aldosterone infusion increased expression of ICAM-1 and VCAM-1 ( Figure 4A ).
Aldosterone also significantly increased endothelium permeability ( Figure 4B ) and CD68 expression ( Figure 4C ), which is highly expressed in monocytes and tissue macrophages. 26 Meanwhile, aldosterone also induced expression of IL1 (interleukin 1) and IL6 ( Figure 4D and 4E) . However, these aldosterone infusion-induced increases in expression of ICAM-1, VCAM-1, CD68, IL1, IL6, as well as increased endothelial permeability were not observed in EnNaC −/− aortic tissues ( Figure 4 ). To determine the role of enhanced αEnNaC activation on oxidative stress, structural parameters, and vascular dysfunction, we evaluated aortic oxidative stress and fibrosis by 3-nitrotyrosine (3-NT), NOX2 (NADPH oxidase 2), and collagen 1 immunostaining, respectively. Chronic aldosterone stimulation increased aortic 3-NT, NOX2, and oxidative stress ( Figure 5 ), that was accompanied by increased collagen 1 expression ( Figure 5 ). Importantly, αEnNaC inactivation attenuated the aldosterone-increased aortic immunostaining for 3-NT, NOX2, as well as collagen 1 expression ( Figure 5 ).
Discussion
This investigation demonstrates that EC-specific deletion of the αEnNaC prevents the development of chronic aldosterone infusion-induced endothelium stiffness and impaired endothelial-mediated relaxation. EnNaC −/− inactivation also reduced inward EC Na + currents as measured by patch clamp, and this reduction in Na + current was associated with reduction of aldosterone-induced endothelium stiffness and associated impairment of endothelium-dependent relaxation. Aldosterone infusion led to increased aortic ER stress, reduction of eNOS activation/relaxation, endothelium permeability, expression of proinflammatory cytokines, and oxidative stress that were involved in an increase in tissue collagen 1 and remodeling. These profibrotic responses to aldosterone were significantly attenuated in EnNaC −/− mice. Generally, the α/β-subunit is essential for proper channel function, whereas the γ-subunit acts as an amplifier, thus each subunit plays an important role in the maintaining ENaC activity and function. 13, 14 However, 1 study has reported that αENaC is not required for β and γENaC to form a channel. 27 Meanwhile, βENaC and γENaC seem to be predominant, whereas αENaC is rare in vascular smooth muscle cells. 28, 29 In Sprague-Dawley rats, vasopressin infusion increases mRNA and protein abundance of ENaC β-and γ-subunits in kidney epithelial cells. 30, 31 Recent studies showed that the expression and activity of ENaC are regulated by flow-induced shear stress in the epithelium of cortical collecting duct, 32 suggesting a role for ENaC in detection and transduction of mechanical forces. Further emphasizing this point, ENaC subunits are molecular components of the arterial baroreceptor complex. 33 Related to this, 1 study has shown that the β/γ-ENaC subunits are expressed in nodose neuronal cell bodies and aortic baroreceptor nerve terminals, whereas the αENaC subunit is undetectable. 34 Meanwhile, the expression of β/γ-ENaC subunits is reduced in aortic baroreceptor nerve terminals in a chronic heart failure rat model. 34 Further, pressure-induced constriction of cerebral arteries is inhibited in a mouse model of reduced β-ENaC, 35 suggesting that ENaC is a molecular component of the arterial baroreceptor mechano-transducer. Moreover, increased EC-specific EnNaC expression and activity significantly links EC-stiffness in both cultured human ECs and Liddle syndrome mouse model. 13 Recent data have also shown that endothelial αEnNaC plays a critical role in regulation of shear-stress sensing and flow-mediated vascular dilation. 17 Collectively, these studies provide strong support for ENaC being involved in vasoregulation, particularly that involving mechanotransduction.
Inhibition of EnNaC with a low dose of amiloride or EC-specific αEnNaC −/− does not affect blood pressure in normal or obese mice. 17, 36 Our previous studies 9 and those of others 37 have shown that ECMR mediated aldosterone-induced EnNaC expression and accumulation on EC membranes is mediated by activation of the EnNaC promoter, increased expression of EnNaC, as well as increases of SGK 1 activity with reduction in ubiquitination of surface EnNaC. The data from the current investigation further supports the notion that αEnNaC subunit activation mediates aldosterone-increased Na + channel activity, inward Na + currents, and endothelial stiffness. To this point, increased Na + entry into EC triggers the polymerization of G-actin to F-actin and the resultant endothelial cortical polymerization and stiffening of the endothelium. 22, 38 Further, gene deletion of aldosterone synthase Cyp11b2 39 and inhibition of ENaC with amiloride 19 attenuates Western diet-induced upregulation of EnNaC, endothelium, and associated aortic stiffness.
In this investigation, aldosterone infusion did not significantly induce an increase in PWV and aortic stiffness. A potential explanation is that aldosterone infusion did not cause dysfunction of vascular smooth muscle cells because aldosterone infusion and αEnNaC deletion did not affect sodium nitroprusside-induced aortic vasodilation. Indeed, increased PWV in aortic stiffness involves the dysfunction of EC, vascular smooth muscle cells, and extracellular matrix. 40, 41 Aldosterone stimulation did induce endothelium dysfunction by upregulation of aortic ER stress as characterized by an increase expression of the critical ER stress protein GRP78. Consistent with this, aldosterone has been found to increase intracellular reactive oxygen species production, ER stress, GRP78 expression, as well as cell apoptosis in renal tubular epithelial cells 42 and vascular ECs. 43 Thus, αEnNaC potentially links ER stress and cell function. In this regard, increased Na + currents affect calcium homeostasis, increases ER stress, and cell death in pancreas β cells as well. 44 Also, increased EnNaC mediated Na currents leads to actin polymerization, 45 which further induces calcium-mediated actin resetting that mediates cell adaptations, ER stress, and EC dysfunction with decreased eNOS activity and NO production. 46, 47 Moreover, ER stress further increases oxidative stress (NOX2/4 mRNA levels and increased nicotinamide adenine dinucleotide phosphate oxidase activity) causes decreases in eNOS promoter activity, eNOS expression, phosphorylation, and thus eNOS activity. 48 These data suggest that αEnNaC activation mediates aldosterone infusion-induced increases in GRP78 expression and reduction of eNOS activity. Consistent with this concept, another study found that increased GRP78 and ER stress promotes expression of ICAM-1 and tumor necrosis factor-α and EC dysfunction through NF-κB (nuclear factor-κB) activation, 49 suggesting that ER stress plays an important role in promoting VCAM-1 expression and monocyte recruitment, 50 which are early inflammatory events in the events leading to increased endothelium stiffness and impaired endothelial eNOS activation.
In this investigation, we also observed that enhanced ECMR signaling and EnNaC activation promoted increased expression of ICAM-1 and VCAM-1, which have previously been associated with increased leukocyte adhesion in human ECs. 51, 52 Increased EC leukocyte adhesion and transmigration have also been shown to be associated with endothelial stiffness. 53 Indeed, endothelial stiffness increases endothelial monolayer tension and permeability and, thus, is regarded as an important factor in impairment of endothelial barrier function. 54 Also consistent with this concept, our previous work demonstrated that Western diet-induced vascular stiffness decreased arterial tight junction proteins, including claudin-5 and occludin and resulted in macrophage recruitment and cardiac fibrosis that were prevented by low dose amiloride. 36 The current research shows that αEnNaC mediates aldosterone-increased endothelium permeability and increased expression of CD68, IL1, and IL6. Because CD68 is highly expressed in monocytes and tissue macrophages, 26 decreased CD68 in EnNaC −/− in the current study suggested αEnNaC mediates monocytes/macrophages infiltration and migration. Meanwhile, both IL1 and IL6 are important mediators in the regulation of immune responses and inflammation, 55 and thus increased expression of IL1 and IL6 may have resulted from activated aortic tissue macrophages.
Increased oxidative stress is associated with increased ENaC activity and salt-sensitive hypertension. Studies have found that reactive oxygen species production mediates ENaC expression and activation. 16, 56 Recent studies have indicated that increased ENaC also promotes oxidative stress in dendritic cells. 57 To this point, Na + enters cells, initiates calcium influx through α/γ-ENaC and the sodium hydrogen exchanger 1, resulting in activation of protein kinase C, phosphorylation of p47 phox , association of p47 phox with gp91 phox , and hypertension. 57 Thus, there is an interaction between ENaC, inward Na + currents, and cellular oxidative stress. Interestingly, endothelial oxidative stress and NOX2 are related to vascular fibrosis and stiffening through proinflammatory effects in angiotensin II-infused transgenic mice. 58 The resultant increase in oxidative stress is associated with activation of profibrotic signaling transforming growth factor beta 1 thereby promoting vascular fibrosis. 59 Our previous data have shown that Western diet-induced increased cardiac NOX2, but not NOX4, expression is mediated by an EnNaCdependent mechanism. 36 These pathophysiological changes contribute to aortic oxidative stress, remodeling, and fibrosis and observed increases in expression of 3-NT, NOX2, and collagen 1 in the aorta. Thus, activation of αEnNaC in the setting of aldosterone-induced vascular dysfunction is associated with increased EC cell permeability, inflammation, and oxidative stress, all of which promote increased endothelial stiffness.
In conclusion, we have extended our previous observations on the role of ECMR-mediated EnNaC activation in promoting arterial stiffness. 19, 36 Current data indicate that aldosterone increases EnNaC membrane abundance and activity in ECs which promotes Na + entry into the endothelium, resulting in increases in GRP78, inflammation, 3-NT, and NOX2 and a reduction of eNOS activity and NO production and a subsequent increase in vascular stiffness, suggesting an important role of ECMR specific αEnNaC activation in increasing endothelial stiffness ( Figure 6 ). These pathophysiological changes are associated with increases in EC inward Na + currents, ER stress, reduction of eNOS activity, increased endothelium adhesion and permeability, and increased expression of proinflammatory molecules and oxidative stress.
Perspectives
The findings in this investigation have important implications in EC function and vascular biology. Increased EC-specific EnNaC expression and activity is associated with EC stiffness and arterial dysfunction. For the first time, we show evidence for an important role of αEnNaC on endothelium permeability, reduction of eNOS activity, inflammation, oxidative stress, as well as endothelium stiffness, thereby providing a potential therapeutic strategy in the prevention of excessive arterial stiffness and associated CVD.
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